TS

Tippu Sulthan Tappa

Active Director Managing Director DIN 10180422
DIN 10180422 First appointment May 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Tippu Sulthan Tappa

Data last updated:

Tippu Sulthan Tappa is a Managing Director at Apthika Pharma Private Limited (since 2023).

DIN 10180422
Primary Designation Managing Director
First Appointment 29 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apthika Pharma Private Limited U46497TS2023PTC173464
Managing Director29 May 20232023Active

Board colleagues of Tippu Sulthan Tappa

NameDINCompanyDesignation
Rampelly Snigdha10180421Apthika Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Apthika Pharma Private Limited
Premium access

Shareholding and investment profile for Tippu Sulthan Tappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tippu Sulthan Tappa

Tippu Sulthan Tappa currently holds 1 directorship: Apthika Pharma Private Limited (Managing Director, since 29 May 2023).

Tippu Sulthan Tappa was first appointed on 29 May 2023 as Managing Director at Apthika Pharma Private Limited.

The current boards of Tippu Sulthan Tappa's companies include Rampelly Snigdha (Apthika Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available